< Zurück zu den aktuellen Neuigkeiten & Events

Neuigkeiten

EPO Fees – changes applying from April 2020

April 2020

The EPO has announced the revised EPO Fees that will apply from 1 April 2020 in its Official Journal.  The new amounts will apply to payments made on or after 1 April 2020.  Most changes, including renewals fees, are in line with inflation, being around a 4% increase.

In some cases, applicants may want to consider the timing for paying fees in relation to their applications to maximise any opportunities to pay lower official fees.  If you would like advice on this, please contact your usual HGF Attorney.  The EPO fee changes are summarised below for your information:

  • Majority of EPO fees to increase by 4%
  • One exception to this is the appeal fee for “typical” appellants, which will rise by 20% from €2,255 to €2,705.  Specific entities set out by the EPO (such as natural persons, small and medium-sized enterprises, non-profit organisations, universities and public research organisations etc) will only see a 4% rise (from €1800 to €1955).  The increase in appeal fee for typical appellants is likely to be related to the ongoing changes and improvements by the EPO Boards of Appeal.
  • Fees for PCT applications, filed via the EPO on or after 1 April 2020 will remain largely unchanged.

Please see all fee changes here.

Aktuelle Neuigkeiten

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Weiterlesen

IAM Global Leaders 2026

HGF is proud to announce that we have 3 partners listed as an IAM Global Leader 2026. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked …

Weiterlesen

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Weiterlesen
Event - 5. November 2025

HGF are Gold Sponsors of IAM Live: Navigating the UPC 2025

We’re excited to share that HGF is a Gold Sponsor of IAM Live: Navigating the UPC 2025, taking place on the 5th November at the Marriott Opera Ambassador Hotel in …

Veranstaltungsdetails

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Weiterlesen

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Weiterlesen
Event - 14. Oktober 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Veranstaltungsdetails

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Weiterlesen